Patents by Inventor Imtiaz Chaudry

Imtiaz Chaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6632842
    Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.
    Type: Grant
    Filed: June 3, 2002
    Date of Patent: October 14, 2003
    Assignee: Dey, L.P.
    Inventors: Imtiaz Chaudry, Partha Banerjee
  • Publication number: 20030191151
    Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 9, 2003
    Inventors: Imtiaz Chaudry, Partha Banerjee
  • Publication number: 20030149007
    Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.
    Type: Application
    Filed: June 3, 2002
    Publication date: August 7, 2003
    Inventors: Imtiaz Chaudry, Partha Banerjee
  • Publication number: 20030140920
    Abstract: The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.
    Type: Application
    Filed: October 18, 2002
    Publication date: July 31, 2003
    Applicant: Dey L.P.
    Inventors: Imtiaz Chaudry, Partha Banerjee
  • Publication number: 20030124063
    Abstract: The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.
    Type: Application
    Filed: December 28, 2001
    Publication date: July 3, 2003
    Inventors: Imtiaz Chaudry, Partha Banerjee
  • Patent number: 4871538
    Abstract: An insoluble copper-alpha interferon complex useful for injectable pharmaceutical compositions is disclosed.
    Type: Grant
    Filed: July 13, 1987
    Date of Patent: October 3, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Martin Zupon, Imtiaz Chaudry